Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of March 2019. The report addresses a corporate governance event regarding a Special General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements.
Material Changes
There are no material financial changes reported. The primary event is the adjournment of the Special General Meeting of Shareholders originally scheduled for March 4, 2019, due to a lack of quorum.
Outlook and Management Commentary
Management has reconvened the Special General Meeting of Shareholders for Monday, March 11, 2019, at 4:00 p.m. (Israel time). The meeting will be held at the Company's offices at 10 Bareket Street, Petach Tikva, Israel. No specific business outlook, risks, or contingencies are detailed in this text.
Key Facts for Investors to Verify
- The Special General Meeting was adjourned on March 4, 2019, due to insufficient shareholder attendance (lack of quorum).
- The rescheduled meeting date is March 11, 2019.
- This filing contains no financial performance data or updated guidance.